Pediatric low-grade glioma (pLGG) is the most common form of pediatric brain cancer. Day One’s OJEMDA™ is the first targeted treatment for pLGG tumors with BRAF fusions and mutations. Last week, on April 23, 2024, Day One Biopharmaceuticals was granted Accelerated […]
Brave Barbie doll provides a friend through treatment for kids with cancer Bethesda, Md. – October 23, 2023 – CureSearch for Children’s Cancer and Mattel are celebrating 10 years of Brave Barbie – a special Barbie created to bring hope
CureSearch, Mattel celebrate 10 years of Brave Barbie Read More »
Bethesda, Md. – January 18, 2023 – CureSearch for Children’s Cancer, a national nonprofit dedicated to ensuring that every child diagnosed with cancer has a safe and effective treatment option, will lead a healthcare economic study to determine how molecular testing
Funds to support cutting-edge immunotherapy trial for pediatric high-grade glioma Bethesda, MD – February 8, 2020 – CureSearch for Children’s Cancer has received a $1 million gift from the Norcross Family Foundation in support of a first-in-human, phase I/II clinical trial testing
CureSearch for Children’s Cancer receives gift to support promising immunotherapy trial Read More »
At CureSearch, we’re dedicated to bringing childhood cancer patients to the forefront of drug development, but we can’t do it alone. Long-term impact will require collaboration among industry leaders and organizations also dedicated to ending childhood cancer. Funding partners like Love Your
CureSearch and Love Your Melon partner to advance childhood cancer research Read More »
FOR IMMEDIATE RELEASE Media Contact: Margetta Thomas, Communications Manager margetta.thomas@curesearch.org Novel immunotherapy approach could improve survival rate for acute myeloid leukemia Bethesda, Md. – September 15, 2021 – CureSearch for Children’s Cancer, in partnership with the SebastianStrong Foundation, has awarded a three-year, $270,650 CureSearch Young Investigator grant
FOR IMMEDIATE RELEASE Media Contact: Margetta Thomas, Communications Manager margetta.thomas@curesearch.org Collaborative forum to address the unique aspects and challenges of pediatric cancer clinical trial design Bethesda, MD – September 9, 2021 – CureSearch for Children’s Cancer will host the virtual 2021 Pediatric Early Development Symposium (PEDS) – Pediatric
Leaders in pediatric oncology converge to improve the next decade of clinical trials Read More »
Dr. Brenda Weigel named Chair of CureSearch Scientific Advisory Council Bethesda, MD – August 26, 2020 – CureSearch for Children’s Cancer announces that Brenda Weigel, MD, has been appointed as the new chair of the CureSearch Scientific Advisory Council. The Council is comprised of best-in-class
Dr. Brenda Weigel named Chair of CureSearch Scientific Advisory Council Read More »
Media Contact: Bailey Singletary240-235-2204Bailey.Singletary@curesearch.org Trent Demulling and David Whan Join CureSearch for Children’s Cancer Board of Directors BETHESDA, MD – August 14, 2020 – CureSearch for Children’s Cancer is pleased to announce the appointment of Trent Demulling and David Whan
CureSearch for Children’s Cancer Announces Board of Directors Additions Read More »
